ZNF692 is a zinc finger transcription factor with dual roles in nucleolar organization and oncogenic transcriptional regulation. Molecularly, ZNF692 functions as a nucleolar scaffold protein that organizes a hub specialized in 40S ribosomal subunit maturation by coordinating the exosome complex and ribosome biogenesis factors 1. ZNF692 directly interacts with nucleophosmin 1 (NPM1) to regulate nucleolar morphology and architecture, promoting efficient protein synthesis in rapidly proliferating cells 2. As a transcriptional regulator, ZNF692 recognizes a specific DNA motif (5'-GCRAGKGGAKAY-3') to repress target genes including IRF4 and FLT4 3. ZNF692 is frequently overexpressed across multiple cancer types, where it promotes proliferation, migration, and invasion through cancer-type specific mechanisms: in cervical cancer via p27kip1 suppression 4, in prostate cancer via EMT pathway regulation 5, in osteosarcoma via TNK2-mediated MEK/ERK activation 6, in lung adenocarcinoma via metabolic pathway modulation 7, and in renal carcinoma via FABP5 regulation 8. Clinical significance: ZNF692 overexpression correlates with poor prognosis and serves as an independent prognostic biomarker across cancers, making it a promising therapeutic target for cancer treatment.